Summary
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma), a subsidiary of Fosun International Limited is a biopharmaceutical and healthcare company that research and develops medical products. The company’s business areas include healthcare services, medicine circulation, and medical diagnosis and medical equipment. Its medical products include oncology drugs, vaccines, metabolism and alimentary system drugs, central nervous system drugs, anti-infection drugs, cardiovascular and blood system, and crude drugs and intermediates. Fosun Pharma offers medical diagnostic products such as real time PCR detector, human papillomavirus genotyping kit, HBV quantitative reagent, and BIOFOSUN microorganism identification and susceptibility analysis system. The company has operations in the US and China. Fosun Pharma is headquartered in Shanghai, China.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Medical Devices Deals, 2010 to YTD 2016 12
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deal Details 17
Venture Financing 17
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 17
Partnerships 19
Nature's Sunshine Products Forms Joint Venture with Fosun Pharma 19
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 21
Maxigen Biotech Enters into Agreement with Shanghai Fosun Pharma 22
Biotest Enters Into Distribution Agreement With Wanbang Biopharma For Human Serum Albumin 23
Shanghai Fosun Enters Into Joint Venture With Dalian Wanchun To Develop Oncology Treatments 24
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 25
Shanghai Fosun Enters Into Joint Venture Agreement With Lonza Group 26
Licensing Agreements 27
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 27
TB Alliance Enters Into Licensing Agreement With Fosun Pharma 28
Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug 30
Equity Offering 31
Shanghai Fosun Pharma Raises USD940 Million in Private Placement of Shares 31
Shanghai Fosun Pharma Decreases Size of Private Placement of Shares for USD376 Million 32
Shanghai Fosun Pharma to Raise Funds through Private Placement of Shares 34
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 35
Nature's Sunshine Raises USD46 Million in Private Placement of Shares 36
Shanghai Fosun Pharma Prices Private Placement Of Shares For US$229.6 Million 38
Chindex International Completes First Closing Of Private Placement Of Common Stock For US$14 Million 39
Debt Offering 41
Shanghai Fosun Pharma Plans to Raise USD928 Million in Private Placement of Bonds 41
Shanghai Fosun Pharma to Raise USD459 Million in First Tranche Public Offering of Bonds Due 2021 42
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 43
Shanghai Fosun Pharma Announces Public Offering Of Corporate Bonds To Raise Up To US$469.8 Million 44
Shanghai Fosun Pharma Completes Offering Of Notes Due 2015 For US$149 Million 45
Asset Transactions 46
Sinopharm Plans to Acquire Pharmacy Business from Shanghai Fosun Pharma 46
Acquisition 47
Shanghai Fosun Pharma to Acquire 2.6% Stake in Jinzhou Austrian Hong Pharma for USD26 Million 47
Shanghai Fosun Pharma, HOPU Investments, CEL Healthcare Fund and WuXi PharmaTech to Acquire Ambrx 48
Shanghai Fosun Pharma Plans to Acquire 65% Stake in Suzhou Erye for USD137 Million 50
Sinopharm Plans to Acquire Three Pharmacies from Shanghai Fosun Pharma for USD67 Million 51
Shanghai Fosun Pharma To Acquire Additional 28% Stake In Jinzhou Aohong Pharma For Up To US$304 Million 52
Fosun Pharma Acquires 50% Stake In Guangzhou Nanyang Tumour Hospital 53
Wanbang Biopharma Acquires 51% Stake In Zaozhuang Sainuokang 54
Shanghai No. 1 Pharmacy Plans To Acquire 50% Stake In Shanghai-Based Chain Pharmacy Company 55
Shanghai Fosun Pharma Completes Acquisition Of 77.78% Stake In Hunan Dongting Pharma For US$93 Million 56
Shanghai Fosun Pharma Completes Acquisition Of 55% Stake In Zhongwu Hospital 57
Fosun Pharma Acquires 11% Stake In Shenzhen Belter For US$7 Million 58
Fosun Pharma Acquires Additional Stake In Beijing Golden Elephant Pharmacy 59
Shanghai Fosun To Sell 68.6% Stake In Zhejiang Fosun To Sinopharm Group 60
Shanghai Fosun Pharma Acquires 75% Stake In Dalian Aleph Bio-medical 61
Shanghai Fosun Acquires 70% Stake In Shenyang Hongqi 62
Shanghai Fosun Pharma Acquires Minority Stake In Biosino Bio-Technology 63
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Key Competitors 65
Key Employees 66
Locations And Subsidiaries 68
Head Office 68
Other Locations & Subsidiaries 68
Appendix 69
Methodology 69
About GlobalData 69
Contact Us 69
Disclaimer 69
List of Tables
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Deals By Therapy Area, 2010 to YTD 2016 10
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Medical Devices Deals, 2010 to YTD 2016 12
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Saladax Biomedical Raises US$23 Million In Series D Venture Financing 17
Nature's Sunshine Products Forms Joint Venture with Fosun Pharma 19
Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 21
Maxigen Biotech Enters into Agreement with Shanghai Fosun Pharma 22
Biotest Enters Into Distribution Agreement With Wanbang Biopharma For Human Serum Albumin 23
Shanghai Fosun Enters Into Joint Venture With Dalian Wanchun To Develop Oncology Treatments 24
Shanghai Fosun Pharma Enters Into Co-Development Agreement With Shanghai Institute of Materia Medica To Develop Cancer Drug 25
Shanghai Fosun Enters Into Joint Venture Agreement With Lonza Group 26
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 27
TB Alliance Enters Into Licensing Agreement With Fosun Pharma 28
Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug 30
Shanghai Fosun Pharma Raises USD940 Million in Private Placement of Shares 31
Shanghai Fosun Pharma Decreases Size of Private Placement of Shares for USD376 Million 32
Shanghai Fosun Pharma to Raise Funds through Private Placement of Shares 34
Amerigen Pharma to Raise USD35 Million in Private Placement of Shares 35
Nature's Sunshine Raises USD46 Million in Private Placement of Shares 36
Shanghai Fosun Pharma Prices Private Placement Of Shares For US$229.6 Million 38
Chindex International Completes First Closing Of Private Placement Of Common Stock For US$14 Million 39
Shanghai Fosun Pharma Plans to Raise USD928 Million in Private Placement of Bonds 41
Shanghai Fosun Pharma to Raise USD459 Million in First Tranche Public Offering of Bonds Due 2021 42
Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 43
Shanghai Fosun Pharma Announces Public Offering Of Corporate Bonds To Raise Up To US$469.8 Million 44
Shanghai Fosun Pharma Completes Offering Of Notes Due 2015 For US$149 Million 45
Sinopharm Plans to Acquire Pharmacy Business from Shanghai Fosun Pharma 46
Shanghai Fosun Pharma to Acquire 2.6% Stake in Jinzhou Austrian Hong Pharma for USD26 Million 47
Shanghai Fosun Pharma, HOPU Investments, CEL Healthcare Fund and WuXi PharmaTech to Acquire Ambrx 48
Shanghai Fosun Pharma Plans to Acquire 65% Stake in Suzhou Erye for USD137 Million 50
Sinopharm Plans to Acquire Three Pharmacies from Shanghai Fosun Pharma for USD67 Million 51
Shanghai Fosun Pharma To Acquire Additional 28% Stake In Jinzhou Aohong Pharma For Up To US$304 Million 52
Fosun Pharma Acquires 50% Stake In Guangzhou Nanyang Tumour Hospital 53
Wanbang Biopharma Acquires 51% Stake In Zaozhuang Sainuokang 54
Shanghai No. 1 Pharmacy Plans To Acquire 50% Stake In Shanghai-Based Chain Pharmacy Company 55
Shanghai Fosun Pharma Completes Acquisition Of 77.78% Stake In Hunan Dongting Pharma For US$93 Million 56
Shanghai Fosun Pharma Completes Acquisition Of 55% Stake In Zhongwu Hospital 57
Fosun Pharma Acquires 11% Stake In Shenzhen Belter For US$7 Million 58
Fosun Pharma Acquires Additional Stake In Beijing Golden Elephant Pharmacy 59
Shanghai Fosun To Sell 68.6% Stake In Zhejiang Fosun To Sinopharm Group 60
Shanghai Fosun Pharma Acquires 75% Stake In Dalian Aleph Bio-medical 61
Shanghai Fosun Acquires 70% Stake In Shenyang Hongqi 62
Shanghai Fosun Pharma Acquires Minority Stake In Biosino Bio-Technology 63
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Key Competitors 65
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Key Employees 66
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Subsidiaries 68
List of Figures
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Medical Devices Deals, 2010 to YTD 2016 12
